randomized controlled trials.

Tata Memorial Develops Rs 100 Tablet to Cut Cancer Recurrence Risk

Tata Memorial Centre (TMC) announces a significant advancement in cancer treatment, unveiling a Rs 100 tablet aimed at mitigating chemotherapy’s…

Read More »